View Older Stories
-
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend
-
Scilex Holding's (SCLX) Scilex Pharmaceuticals Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals
-
Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Pre
-
Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Sha
-
UPDATE -- Scilex Holding Company Files Emergency Motion in the United States Bankruptcy Court for the Southern District of Texas for Entry of an Order Compelling the Production of Books and Records fr
-
Scilex Holding Company Files Emergency Motion in the United States Bankruptcy Court for the Southern District of Texas for Entry of an Order Compelling the Production of Books and Records from certain
-
Scilex Holding (SCLX) Issues Notice to All Lenders of Short Positions in the Restricted Dividend Shares of Scilex Holding Company
-
Scilex Holding Company Provides Notice to All Lenders of Short Positions in the Restricted Dividend Shares of Scilex Holding Company
-
Scilex Holding Company Provides Notice to All Record Holders and Beneficial Owners of Restricted Shares of Scilex Holding Company
-
Sorrento Therapeutics (SRNEQ) Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding
-
Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Co
-
Oramed Pharma (ORMP) Announces $101.88M Short-Term Senior Secured Note Transaction with Scilex Holding Company
-
Scilex Holding (SCLX) Enters Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, and Warrants Currently Owned by Sorrento
-
Scilex Holding Company Enters into Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, and Warrants Currently Owned by Sorrento Therapeutics, Inc. and is Dec
-
Virpax Pharmaceuticals (VRPX) Pharmaceuticals Updates on Litigation
-
Virpax Pharmaceuticals Updates on Litigation
-
ImmunityBio's (IBRX) NantCell Statement on Sorrento's (SCLX) Failure to Pay Settlement
-
Scilex Holding (SCLX) Announces Court Approval of Oramed Transaction; Board and Admin Changes
-
Sorrento Issues a “FAQ” in Response to Large Number Of Urgent Requests from Scilex Dividend Short Holders and/or Record Holders
-
Sorrento Announces Launch of Voluntary Offering to Dividend Short Holders with Deadline to Participate by July 27, 2023
-
/C O R R E C T I O N -- Sorrento Therapeutics, Inc./
-
Sorrento Therapeutics' (SRNEQ) Bankruptcy Court Approves Elective Offering of Restricted Common Stock of Scilex Holding Company for Dividend Short Holders
-
Sorrento Therapeutics, Inc.'s Bankruptcy Court Approves Elective Offering of Restricted Common Stock of Scilex Holding Company for Dividend Short Holders
-
Scilex Holding (SCLX) Announces 13.27M Share Offering
-
Scilex Holding (SCLX) Announces 13.27M Share Offering
-
Scilex (SCLX) Announces that Sorrento Therapeutics' Bankruptcy Court Issues Temporary Restraining Order Against Brokerage Firms and Suspends Short-Sales of Dividended Scilex Stock
-
Scilex Holding Company Announces that Sorrento Therapeutics, Inc.’s Bankruptcy Court Issues Temporary Restraining Order Against Brokerage Firms and Suspends Short-Sales of Dividended Scilex Stock
-
Sorrento Therapeutics, Inc.'s Bankruptcy Court Issues Temporary Restraining Order Against Brokerage Firms and Suspends Short-Sales of Dividended Scilex Stock
-
Sorrento's (SRNEQ) Bankruptcy Court Orders Brokerage Firms to Credit Dividended Scilex Stock to Customers' Accounts and Sorrento Advises Holders of Dividended Scilex Stock to Contact Brokerage Firms t
-
Sorrento Therapeutics, Inc.'s Bankruptcy Court Orders Brokerage Firms to Credit Dividended Scilex Stock to Customers' Accounts and Sorrento Advises Holders of Dividended Scilex Stock to Contact Broker
-
Scilex Holding (SCLX) Announces Sorrento Therapeutics' Bankruptcy Court Extended the Lockup Period on Shares of Scilex Stock Distributed by Sorrento as Dividend
-
Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Notice that Sorrento’s Bankruptcy Court has Extended the Lockup Period on Shares of Scilex S
-
Scilex Holding Company Announces Final Postponement of Annual Meeting of Stockholders
-
Sorrento Therapeutics' Scilex (SCLX) Subsidiary Considers Issuing New Stock - WSJ
-
Scilex Holding Company Announces Postponement of Annual Meeting of Stockholders
-
Sorrento's (SRNEQ) Bankruptcy Court Requires Brokerages to Provide Information Related to Scilex Common Stock
-
Sorrento Therapeutics, Inc.'s Bankruptcy Court Requires Brokerages to Provide Information Related to Scilex Common Stock
-
Sorrento Therapeutics (SRNE) Granted Court Approval for $75M Financing in Chapter 11 Case
-
Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case
-
Sorrento Posts Form 8937 to Supplement its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, “Scilex”)
-
Sorrento Therapeutics (SRNE) Receives Court Approval for "First Day" Employee Wages and Cash Management Motions
-
Sorrento Therapeutics, Inc. Receives Court Approval for "First Day" Employee Wages and Cash Management Motions
-
Joint Statement by Sorrento Therapeutics, Inc. and Scilex Holding Company on Today’s Isolated Chapter 11 Filing By Sorrento Therapeutics, Inc.

